European Union 
Co-financing from the state budget PRICE INQUIRY No. SEMA/32/PR48126/2024 - being conducted as a market assessment study
In connection with the implementation of the project titled “Design and development of an innovative solution – a generic drug of the GLP-1 receptor agonist class for the treatment of type 2 diabetes”,” funded from the state budget by the Medical Research Agency, WZA Polfa Warszawa S.A., you are kindly requested to submit a bid for the synthesis and supply of peptides.
Details of the price inquiry can be found in the documents attached below.
go back